NS3-targeting LSP vaccine (Vaxeal)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNS3-targeting LSP vaccine (Vaxeal)
Drug Alias Namehepatitis C vaccine (Vaxeal)NS3-targeting long synthetic peptide vaccine (Vaxeal)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHepatitis C virus (HCV) nonstructural protein 3 inhibitors
TargetsHepatitis C virus (HCV) nonstructural protein 3
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesCommissariat A L'Energie Atomique
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaizhou China Medical City Asset Management Co LtdVaxeal Holding SA
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A